Publication planning is one of the most important components of a communications strategy for a drug or device, and it forms the base upon which pharma companies can share key scientific data on a product and spread awareness. A requirement in many countries, publishing critical data from clinical trials informs key external stakeholders of a [...]

At Six Degrees Medical (SDM), we take the work we do very seriously. As experts in medical communications, we understand that our contributions help our clients to deliver life-changing pharmaceutical treatments into the hands of the patients who need them most. We’re driven by a purpose bigger than simply punching the clock in a 9 [...]

The word “eLearning” has come so far since it was first coined in 1999.[1] Twenty years later, eLearning reaches far beyond the confines of the simple lowercase “e” for electronic. It is highly adaptable, often social and usually competitive. Continuing technological advances in virtual reality, augmented reality, artificial intelligence, and more are transforming the learning [...]

Trends to watch in 2019 include an increasing emphasis on highly targeted drugs; new healthcare applications for artificial intelligence (AI) and machine learning (ML); eMeeting innovations; and pressure to reduce drug prices while improving patient outcomes. The following is a round-up of what we’re expecting to see this year: Outcome-Based Care Payers, healthcare professionals and [...]

Major news from 2018 was the FDA’s announcement of upcoming changes to  the processes of the drug review office. Included in the modernization, per a written statement[1] from the FDA Commissioner Scott Gottlieb, is to provide FDA scientists and medical officers the opportunity to become “thought leaders”[2] in their fields. The proposals for change include [...]